Abstract
Human pluripotent stem cells (hPSCs), with their unique characteristics for indefinite proliferation and pluripotency, are an appealing source for cell replacement therapies, tissue engineering, drug discovery and in vitro toxicology. For the clinical implementation of these cells, there is the need for translating the culture protocols developed at research laboratories into validated bioprocesses that can guarantee reproducibility, scalability, standardization, robustness and safety.
The most attractive strategy for hPSC manufacturing consists in engineering stem cell niches by identifying key factors governing hPSC cell fate and creating culturing approaches that allow for 3D cell organization in a bioreactor-based system where the key environmental conditions are finely controlled. This chapter provides an overview of current bioengineering strategies that could be used to generate large numbers of hPSCs and/or their derivatives with potential application in regenerative medicine and drug discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Amit M, Chebath J, Margulets V, Laevsky I, Miropolsky Y, Shariki K, Peri M, Blais I, Slutsky G, Revel M, Itskovitz-Eldor J (2010) Suspension culture of undifferentiated human embryonic and induced pluripotent stem cells. Stem Cell Rev 6:248–259
Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, Ando S, Sugiura M, Ideno H, Shimada A, Nifuji A, Abe M (2013) Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature. doi:10.1038/nature11807
Ao A, Hao J, Hong CC (2011) Regenerative chemical biology: current challenges and future potential. Chem Biol 18:413–424
Ardehali R, Inlay MA, Ali SR, Tang C, Drukker M, Weissman IL (2011) Overexpression of BCL2 enhances survival of human embryonic stem cells during stress and obviates the requirement for serum factors. Proc Natl Acad Sci U S A 108:3282–3287
Azarin SM, Palecek SP (2010) Development of scalable culture systems for human embryonic stem cells. Biochem Eng J 48:378
Bai H, Chen K, Gao YX, Arzigian M, Xie YL, Malcosky C, Yang YG, Wu WS, Wang ZZ (2012) Bcl-xL enhances single-cell survival and expansion of human embryonic stem cells without affecting self-renewal. Stem Cell Res 8:26–37
Bauwens CL, Peerani R, Niebruegge S, Woodhouse KA, Kumacheva E, Husain M, Zandstra PW (2008) Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells 26:2300–2310
Brandenberger R, Burger S, Campbell A, Fong T, Lapinskas E, Rowley JA (2012) Cell therapy bioprocessing: integrating process and product development for the next generation of biotherapeutics. BioProcess Int 10:30–37
Brignier AC, Gewirtz AM (2010) Embryonic and adult stem cell therapy. J Allergy Clin Immunol 125:S336–S344
Burdick JA, Vunjak-Novakovic G (2009) Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 15:205–219
Burdick JA, Watt FM (2011) High-throughput stem-cell niches. Nat Methods 8:915–916
Cameron CM, Hu WS, Kaufman DS (2006) Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation. Biotechnol Bioeng 94:938–948
Chayosumrit M, Tuch B, Sidhu K (2010) Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biomaterials 31:505–514
Chen AK, Chen X, Choo AB, Reuveny S, Oh SK (2010) Expansion of human embryonic stem cells on cellulose microcarriers. Curr Protoc Stem Cell Biol. doi:10.1002/9780470151808.sc01c11s14, Chapter 1: Unit 1C 11
Chen AK, Chen X, Choo AB, Reuveny S, Oh SK (2011) Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res 7:97–111
Cimetta E, Figallo E, Cannizzaro C, Elvassore N, Vunjak-Novakovic G (2009) Micro-bioreactor arrays for controlling cellular environments: design principles for human embryonic stem cell applications. Methods 47:81–89
Collin J, Lako M (2011) Concise review: putting a finger on stem cell biology: zinc finger nuclease-driven targeted genetic editing in human pluripotent stem cells. Stem Cells 29:1021–1033
Come J, Nissan X, Aubry L, Tournois J, Girard M, Perrier AL, Peschanski M, Cailleret M (2008) Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system. Tissue Eng Part C Methods 14:289–298
Crook JM, Peura TT, Kravets L, Bosman AG, Buzzard JJ, Horne R, Hentze H, Dunn NR, Zweigerdt R, Chua F, Upshall A, Colman A (2007) The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell 1:490–494
Cukierman E, Pankov R, Yamada KM (2002) Cell interactions with three-dimensional matrices. Curr Opin Cell Biol 14:633–639
Dang SM, Gerecht-Nir S, Chen J, Itskovitz-Eldor J, Zandstra PW (2004) Controlled, scalable embryonic stem cell differentiation culture. Stem Cells 22:275–282
Delcroix GJ, Schiller PC, Benoit JP, Montero-Menei CN (2010) Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials 31:2105–2120
Discher DE, Mooney DJ, Zandstra PW (2009) Growth factors, matrices, and forces combine and control stem cells. Science 324:1673–1677
Ezashi T, Das P, Roberts RM (2005) Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A 102:4783–4788
Fernandes AM, Marinho PA, Sartore RC, Paulsen BS, Mariante RM, Castilho LR, Rehen SK (2009) Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz J Med Biol Res 42:515–522
Ferreira LS, Gerecht S, Fuller J, Shieh HF, Vunjak-Novakovic G, Langer R (2007) Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials 28:2706–2717
Fong WJ, Tan HL, Choo A, Oh SK (2005) Perfusion cultures of human embryonic stem cells. Bioprocess Biosyst Eng 27:381–387
Forsyth NR, Musio A, Vezzoni P, Simpson AH, Noble BS, McWhir J (2006) Physiologic oxygen enhances human embryonic stem cell clonal recovery and reduces chromosomal abnormalities. Cloning Stem Cells 8:16–23
Gareau T, Lara GG, Shepherd RD, Krawetz R, Rancourt DE, Rinker KD, Kallos MS (2012) Shear stress influences the pluripotency of murine embryonic stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med. doi:10.1002/term.1518
Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R Vunjak-Novakovic G (2007) Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 104:11298–11303
Gerecht-Nir S, Cohen S, Itskovitz-Eldor J (2004) Bioreactor cultivation enhances the efficiency of human embryoid body (hEB) formation and differentiation. Biotechnol Bioeng 86:493–502
Heng BC, Li J, Chen AK, Reuveny S, Cool SM, Birch WR, Oh SK (2012) Translating human embryonic stem cells from 2-dimensional to 3- dimensional cultures in a defined medium on laminin- and vitronectin-coated surfaces. Stem Cells Dev 21(10):1701–1715
Hentze H, Graichen R, Colman A (2007) Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol 25:24–32
Hernandez RM, Orive G, Murua A, Pedraz JL (2010) Microcapsules and microcarriers for in situ cell delivery. Adv Drug Deliv Rev 62:711–730
Jensen J, Hyllner J, Bjorquist P (2009) Human embryonic stem cell technologies and drug discovery. J Cell Physiol 219:513–519
Jin S, Yao H, Weber JL, Melkoumian ZK, Ye K (2012) A synthetic, xeno-free peptide surface for expansion and directed differentiation of human induced pluripotent stem cells. PLoS One 7(11):e50880
Jing D, Parikh A, Canty JM Jr, Tzanakakis ES (2008) Stem cells for heart cell therapies. Tissue Eng Part B Rev 14:393–406
Jing D, Parikh A, Tzanakakis ES (2010) Cardiac cell generation from encapsulated embryonic stem cells in static and scalable culture systems. Cell Transplant 19:1397–1412
Kehoe DE, Jing D, Lock LT, Tzanakakis EM (2009) Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A 16:405–421
King JA, Miller WM (2007) Bioreactor development for stem cell expansion and controlled differentiation. Curr Opin Chem Biol 11:394–398
Kirouac DC, Ito C, Csaszar E, Roch A, Yu M, Sykes EA, Bader GD, Zandstra PW (2010) Dynamic interaction networks in a hierarchically organized tissue. Mol Syst Biol 6:417
Kolhar P, Kotamraju VR, Hikita ST, Clegg DO, Ruoslahti E (2010) Synthetic surfaces for human embryonic stem cell culture. J Biotechnol 146:143–146
Krawetz R, Taiani JT, Liu S, Meng G, Li X, Kallos MS, Rancourt D (2010) Large-scale expansion of pluripotent human embryonic stem cells in stirred suspension bioreactors. Tissue Eng Part C Methods 16:573–582
Lamba DA, McUsic A, Hirata RK, Wang PR, Russell D, Reh TA (2010) Generation, purification and transplantation of photoreceptors derived from human induced pluripotent stem cells. PLoS One 5:e8763
Lecina M, Ting S, Choo A, Reuveny S, Oh S (2010) Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods 16:1609–1619
Lee WY, Kim J, Gil CH, Lee JH, Song H, Kim JH, Chung HM (2011) Maintenance of human pluripotent stem cells using 4SP-hFGF2-secreting STO cells. Stem Cell Res 7:210–218
Leung HW, Chen A, Choo AB, Reuveny S, Oh SK (2011) Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng Part C Methods 17:165–172
Li Y, Gautam A, Yang J, Qiu L, Melkoumian Z, Weber J, Telukuntla L, Srivastava R, Whiteley E, Brandenberger R (2013) Differentiation of oligodendrocyte progenitor cells from human embryonic stem cells on vitronectin-derived synthetic peptide acrylate surface. Stem Cells Dev 22(10):1497–1505
Lim DY, Ng YH, Lee J, Mueller M, Choo AB, Wong VV (2011) Cytotoxic antibody fragments for eliminating undifferentiated human embryonic stem cells. J Biotechnol 153:77–85
Lindvall O, Kokaia Z, Martinez-Serrano A (2004) Stem cell therapy for human neurodegenerative disorders – how to make it work. Nat Med 10(Suppl):S42–S50
Lock LT, Tzanakakis ES (2007) Stem/progenitor cell sources of insulin-producing cells for the treatment of diabetes. Tissue Eng 13:1399–1412
Lock LT, Tzanakakis ES (2009) Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A 15:2051–2063
Lui KO, Waldmann H, Fairchild PJ (2009) Embryonic stem cells: overcoming the immunological barriers to cell replacement therapy. Curr Stem Cell Res Ther 4:70–80
Lukashev ME, Werb Z (1998) ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 8:437–441
Lund AW, Yener B, Stegemann JP, Plopper GE (2009) The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination. Tissue Eng Part B Rev 15:371–380
Maia J, Santos T, Aday S, Agasse F, Cortes L, Malva JO, Bernardino L, Ferreira L (2011) Controlling the neuronal differentiation of stem cells by the intracellular delivery of retinoic acid-loaded nanoparticles. ACS Nano 5:97–106
Melkoumian Z, Weber JL, Weber DM, Fadeev AG, Zhou Y, Dolley-Sonneville P, Yang J, Qiu L, Priest CA, Shogbon C, Martin AW, Nelson J, West P, Beltzer JP, Pal S, Brandenberger R (2010) Synthetic peptide-acrylate surfaces for long-term self-renewal and cardiomyocyte differentiation of human embryonic stem cells. Nat Biotechnol 28:606–610
Millman JR, Tan JH, Colton CK (2009) The effects of low oxygen on self-renewal and differentiation of embryonic stem cells. Curr Opin Organ Transplant 14:694–700
Mohamet L, Lea ML, Ward CM (2010) Abrogation of E-cadherin-mediated cellular aggregation allows proliferation of pluripotent mouse embryonic stem cells in shake flask bioreactors. PLoS One 5:e12921
Murua A, Portero A, Orive G, Hernandez RM, de Castro M, Pedraz JL (2008) Cell microencapsulation technology: towards clinical application. J Control Release 132:76–83
Nie Y, Bergendahl V, Hei DJ, Jones JM, Palecek SP (2009) Scalable culture and cryopreservation of human embryonic stem cells on microcarriers. Biotechnol Prog 25:20–31
Niebruegge S, Bauwens CL, Peerani R, Thavandiran N, Masse S, Sevaptisidis E, Nanthakumar K, Woodhouse K, Husain M, Kumacheva E, Zandstra PW (2009) Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor. Biotechnol Bioeng 102:493–507
Oh SK, Chen AK, Mok Y, Chen X, Lim UM, Chin A, Choo AB, Reuveny S (2009) Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res 2:219–230
Olmer R, Haase A, Merkert S, Cui W, Palecek J, Ran C, Kirschning A, Scheper T, Glage S, Miller K, Curnow EC, Hayes ES, Martin U (2010) Long term expansion of undifferentiated human iPS and ES cells in suspension culture using a defined medium. Stem Cell Res 5:51–64
Pampaloni F, Reynaud EG, Stelzer EH (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8:839–845
Phillips BW, Horne R, Lay TS, Rust WL, Teck TT, Crook JM (2008) Attachment and growth of human embryonic stem cells on microcarriers. J Biotechnol 138:24–32
Placzek MR, Chung IM, Macedo HM, Ismail S, Mortera Blanco T, Lim M, Cha JM, Fauzi I, Kang Y, Yeo DC, Ma CY, Polak JM, Panoskaltsis N, Mantalaris A (2009) Stem cell bioprocessing: fundamentals and principles. J R Soc Interface 6:209–232
Powers DE, Millman JR, Bonner-Weir S, Rappel MJ, Colton CK (2010) Accurate control of oxygen level in cells during culture on silicone rubber membranes with application to stem cell differentiation. Biotechnol Prog 26:805–818
Purpura KA, Aubin JE, Zandstra PW (2004) Sustained in vitro expansion of bone progenitors is cell density dependent. Stem Cells 22:39–50
Ramos-Mejia V, Fernandez AF, Ayllon V, Real PJ, Bueno C, Anderson P, Martin F, Fraga MF, Menendez P (2011) Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification. Stem Cells Dev 21(9):1549–1558
Rodin S, Domogatskaya A, Strom S, Hansson EM, Chien KR, Inzunza J, Hovatta O, Tryggvason K (2010) Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 28:611–615
Saha K, Mei Y, Reisterer CM, Pyzocha NK, Yang J, Muffat J, Davies MC, Alexander MR, Langer R, Anderson DG, Jaenisch R (2011) Surface-engineered substrates for improved human pluripotent stem cell culture under fully defined conditions. Proc Natl Acad Sci U S A 108:18714–18719
Schriebl K, Satianegara G, Hwang A, Tan HL, Fong WJ, Yang HH, Jungbauer A, Choo A (2012) Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody. Tissue Eng Part A 18:899–909
Selvaraj V, Plane JM, Williams AJ, Deng W (2010) Switching cell fate: the remarkable rise of induced pluripotent stem cells and lineage reprogramming technologies. Trends Biotechnol 28:214–223
Serra M, Brito C, Sousa MF, Jensen J, Tostoes R, Clemente J, Strehl R, Hyllner J, Carrondo MJ, Alves PM (2010) Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol 148:208–215
Serra M, Brito C, Correia C, Alves PM (2012) Process engineering human pluripotent stem cells for clinical applications. Trends Biotechnol 30(6):350–359
Serra M, Correia C, Malpique R, Brito C, Jensen J, Bjorquist P, Carrondo MJ, Alves PM (2011) Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One 6:e23212
Singh H, Mok P, Balakrishnan T, Rahmat SN, Zweigerdt R (2010) Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res 4:165–179
Siti-Ismail N, Bishop AE, Polak JM, Mantalaris A (2008) The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 29:3946–3952
Storm MP, Orchard CB, Bone HK, Chaudhuri JB, Welham MJ (2010) Three-dimensional culture systems for the expansion of pluripotent embryonic stem cells. Biotechnol Bioeng 107:683–695
Tang C, Lee AS, Volkmer JP, Sahoo D, Nag D, Mosley AR, Inlay MA, Ardehali R, Chavez SL, Pera RR, Behr B, Wu JC, Weissman IL, Drukker M (2011) An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat Biotechnol 29:829–834
Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA (2005) Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366:2019–2025
Tsai RY, McKay RD (2000) Cell contact regulates fate choice by cortical stem cells. J Neurosci 20:3725–3735
Tzanakakis ES, Hess DJ, Sielaff TD, Hu WS (2000) Extracorporeal tissue engineered liver-assist devices. Annu Rev Biomed Eng 2:607–632
Unger C, Skottman H, Blomberg P, Dilber MS, Hovatta O (2008) Good manufacturing practice and clinical-grade human embryonic stem cell lines. Hum Mol Genet 17:R48–R53
Veraitch FS, Scott R, Wong JW, Lye GJ, Mason C (2008) The impact of manual processing on the expansion and directed differentiation of embryonic stem cells. Biotechnol Bioeng 99:1216–1229
Villa-Diaz LG, Nandivada H, Ding J, Nogueira-de-Souza NC, Krebsbach PH, O'Shea KS, Lahann J, Smith GD (2010) Synthetic polymer coatings for long-term growth of human embryonic stem cells. Nat Biotechnol 28:581–583
Yirme G, Amit M, Laevsky I, Osenberg S, Itskovitz-Eldor J (2008) Establishing a dynamic process for the formation, propagation, and differentiation of human embryoid bodies. Stem Cells Dev 17:1227–1241
Zhao F, Grayson WL, Ma T, Irsigler A (2009) Perfusion affects the tissue developmental patterns of human mesenchymal stem cells in 3D scaffolds. J Cell Physiol 219:421–429
Zhao T, Zhang ZN, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474:212–215
Zweigerdt R, Olmer R, Singh H, Haverich A, Martin U (2011) Scalable expansion of human pluripotent stem cells in suspension culture. Nat Protoc 6:689–700
Acknowledgments
The authors would like to acknowledge the financial support received from the Portuguese Foundation for Science and Technology (PTDC/BIO/72755/2006) and from the European Commission (Cell Programming by Nanoscaled Devices, NMP4-CT-2004-500039; Clinigene Network of Excellence, LSHB-CT-2006-018933; HYPERLAB - high yield and performance stem cell lab, 223011).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Serra, M., Correia, C., Brito, C., Alves, P.M. (2014). Bioprocessing of Human Pluripotent Stem Cells for Cell Therapy Applications. In: Al-Rubeai, M., Naciri, M. (eds) Stem Cells and Cell Therapy. Cell Engineering, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-7196-3_4
Download citation
DOI: https://doi.org/10.1007/978-94-007-7196-3_4
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-7195-6
Online ISBN: 978-94-007-7196-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)